Gilead Sciences (GILD) Accounts Payables (2009 - 2026)
Gilead Sciences' Accounts Payables was $674 million in Q2 2026, up 15.8% from $582 million a year earlier and up 4.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Accounts Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Gilead Sciences came in at $715 million, down 14.2% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $833 million in FY2024 (+51.5%), $550 million in FY2023 (-39.2%), $905 million in FY2022 (+28.4%) and $705 million in FY2021 (-83.7%).
- Quarterly Accounts Payables has moved between $537 million (Q2 2024) and $905 million (Q4 2022) over five years.
- Compared with a year earlier, Accounts Payables was higher in five of the last eight quarters, with growth averaging 13.9%.
- The best year-over-year quarter for Accounts Payables over five years was Q3 2024 (growth of 54.1%); the worst was Q4 2021 (a decline of 83.7%).
- Per Business Quant data, GILD's Accounts Payables in the three quarters before Q2 2026 was $645 million (Q1 2026), $715 million (Q4 2025) and $808 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 674.00 Mn |
| Mar 31, 2026 | 645.00 Mn |
| Dec 31, 2025 | 715.00 Mn |
| Sep 30, 2025 | 808.00 Mn |
| Jun 30, 2025 | 582.00 Mn |
| Mar 31, 2025 | 737.00 Mn |
| Dec 31, 2024 | 833.00 Mn |
| Sep 30, 2024 | 903.00 Mn |
| Jun 30, 2024 | 537.00 Mn |
| Mar 31, 2024 | 622.00 Mn |
| Dec 31, 2023 | 550.00 Mn |
| Sep 30, 2023 | 586.00 Mn |
| Jun 30, 2023 | 622.00 Mn |
| Mar 31, 2023 | 627.00 Mn |
| Dec 31, 2022 | 905.00 Mn |
| Sep 30, 2022 | 614.00 Mn |
| Jun 30, 2022 | 565.00 Mn |
| Mar 31, 2022 | 583.00 Mn |
| Dec 31, 2021 | 705.00 Mn |
| Sep 30, 2021 | 585.00 Mn |
API Access
Gilead Sciences Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();